Towards predictive structure-based models of evolved drug resistance

2012 IEEE Symposium on Computational Intelligence and Computational Biology, CIBCB 2012

Volumn , Issue , 2012, Pages 120-126

  Hecht, David ^a   Fogel, Gary B ^b  

^a Southwestern College   (United States)

^b NATURAL SELECTION INC   (United States)

Author keywords

coevolution; drug discovery; drug resistance; In silico evolution; malaria

Indexed keywords

CO-EVOLUTION; DRUG DISCOVERY; DRUG RESISTANCE; IN-SILICO; MALARIA;

AMINO ACIDS; ARTIFICIAL INTELLIGENCE; DISEASES; DOCKING;

BIOINFORMATICS;

EID: 84864040343     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/CIBCB.2012.6217220     Document Type: Conference Paper

References (31)

1. J.E. Hyde, "Mechanisms of resistance of Plasmodium falciparum toantimalarial drugs," Microbes Infect. 4 (2002) 165-174.
2. Y. Yuthavong, "Basis for antifolate action and resistance in malaria," Microbes Infect. 4 (2002) 175-182.
3. R. Ferone, "Folate metabolism in malaria,." Bull. World Health Organ.55 (1977) 291-298.
4. J. Yuvaniyama, P. Chitnumsub, S. Kamchonwongpaison, J. Vanichtanankul, W. Sirawaraporn, P. Taylor, M. Walkinshaw, Y. Yuthavong, "Insights into antifolate resistance from malarial DHFR-TS structures," Nat. Struct. Biol. 10 (2003) 357-365.
5. W. Sirawaraporn, T. Sathikul, R. Sirawaraporn, Y. Yuthavong, D.V. Santi, "Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase," Proc. Natl. Acad. Sci. 94 (1997) 1124-1129.
6. P. Kongsaeree, P. Khongsuk, U. Leartsakulpanich, P. Chitnumsub, B. Tarnchombpoo, M.D. Walkinshaw, Y. Yuthavong, "Crystal structure of dihydrofolate reductase from Plasmodium vivax: pyrimethamine displacement linked with mutation-induced resistance," Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 13046-13051.
7. C. Mehlin, "Structure-based drug discovery for Plasmodium falciparum," Comb. Chem. High Throughput Screen. 8 (2005) 5-14.
8. R.L. Brady, A. Cameron, "Structure-based approaches to the development of novel anti-malarials," Curr. Drug Targets 5 (2004) 137-149.
9. R.T. Delfino, O.A. Santos-Filho, J.D. Figueroa-Villar, "Molecular modeling of wild-type and antifolate resistant mutant Plasmodium falciparum DHFR," Biophys. Chem. 98 (2002) 287-300.
10. S. Kamchonwongpaison, R. Quarrell, N. Charoensetakul, R. Ponsinet, T. Vilaivan, J. Vanichtanankul,W. Tarnchampoo,W. Sirawaraporn, G. Lowe, Y. Yuthavong, "Inhibitors of multiple mutants of Plasmodium falciparum dihydrofolate reductase and their antimalarial activities," J. Med. Chem. 47 (2004) 673-680.
11. S. Kamchonwongpaison, J. Vanichtanankul, B. Tarnchampoo, J. Yuvaniyama, S. Taweechai, Y. Yuthavong, "Stoichiometric selection of tightbinding inhibitors by wild-type and mutant forms of malarial (Plasmodium falciparum) dihydrofolate reductase," Anal. Chem. 77 (2005) 1222-1227.
12. M.D. Parenti, S. Pacchioni, A.M. Ferrari, G. Rastelli, "Three-dimensional quantitative structure-activity relationship analysis of a set of Plasmodium falciparum dihydrofolate reductase inhibitors using a pharmacophore generation approach," J. Med. Chem. 47 (2004) 4258-4267.
13. V.K. Agrawal, R. Sohgaura, P.V. Khadikar, "QSAR studies on biological activity of piritrexium analogues against pc DHFR," Bioorg. Med. Chem. 10 (2002) 2919-2926.
14. B.E. Mattioni, P.C. Jurs, "Prediction of dihyrdrofolate reductase inhibition and selectivity using computational neural networks and linear discriminant analysis," J. Mol. Graph. Model. 21 (2003) 391-419.
15. A. Gangjee, X. Lee, "CoMFA and CoMSIA analyses of Pneumocystis carinii dihydrofolate reductase, and rat liver dihydrofolate reductase," J. Med. Chem. (2005) 1448-1469.
16. J.J. Sutherland, D.F. Weaver, "Three-dimensional quantitative structure-activity and structure-selectivity relationships of dihydrofolate reductase inhibitors," J. Comput. Aided Drug Des. 18 (2004) 309-331.
17. A. Ganjee, X. Lin, "CoMFA and CoMSIA analyses of Pneumocystis carinii dihydrofolate reductase, Toxoplasma gondii dihydrofolate reductase, and rat liver dihydrofolate reductase," J. Med. Chem. 48 (2005) 1448-1469.
18. O.A. Santos-Filho, A.J. Hopfinger, "A search for sources of dru resistance by the 4D-QSAR analysis of a set of anti-malarial dihydrofolate reductase inhibitors," J. Comput. Aided Mol. Des. 15 (2001) 1-12.
19. T.-L. Chiu, S.-S. So, "Development of neural network QSPR Models for hansch substituent constants. 2. Applications in QSAR studies of HIV-1 reverse transcriptase and dihydrofolate reductase inhibitors," J. Chem. Inf.Comput. Sci. 44 (2004) 154-160.
20. GB Fogel, M. Cheung, E. Pittman, D. Hecht, "In Silico Screening Against Wild-Type and Mutant Plasmodium falciparum Dihydrofolate Reductase", J.Molecular Graphics and Modelling, 26 (2008) 1145-1152.
21. GB Fogel, M. Cheung, E. Pittman, D. Hecht, "Modeling the Inhibition of Quadruple Mutant Plasmodium falciparum Dihydrofolate Reductase by Pyrimethamine Derivatives," J. Comput. Aided Mol. Des., 22 (2008) 29-38.
22. D. Hecht, M. Cheung., GB Fogel, "QSAR Using Evolved Neural Networks for the Inhibition of Mutant PfDHFR by Pyrimethamine Derivatives," Biosystems, 92 (2008) 10-15.
23. D. Hecht, M. Cheung, GB Fogel, "Docking Scores and QSAR Using Evolved Neural Networks for the Pan-Inhibition of Wild-type and Mutant PfDHFR by Cycloguanil Derivatives," 2009 IEEE Congress on Evolutionary Computation, Trondheim, Norway (2009) 262-269.
24. D. Hecht, GB Fogel, "A novel in silico approach to drug discovery via computational intelligence," J Chem Inf Model., 49 (2009) 1105-21.
25. R.M. Bush, "Predicting adaptive evolution," Nature Reviews Genetics 2, (2001) 387-392.
26. W.M. Fitch, R.M. Bush, C.A. Bender, K. Subbarao, N.J. Cox, "Predicting the evolution of human influenza A," Journal of Heredity 91 (2000) 183-185.
27. D. Hecht, J. Tran, G.B. Fogel, "Structure-based anaylsis of dihydrofolate reductcase evolution," Molecular Phylogenetics and Evolution 61 (2011) 212-230.
28. J. Wang, P. Cieplak, P.A. Kollman, "How Well Does a Restrained Electrostatic Potential (RESP) Model Perform in Calculating Conformational Energies of Organic and Biological Molecules," J. Comput. Chem. Vol. 21, pp.1049-1074.
29. G. Jones, P. Willett, R. C. Glen, A. R. Leach and R. Taylor, "Development and Validation of a Genetic Algorithm for Flexible Docking," J. Mol. Biol. 267 (1997) 727-748.
30. O. Korb, T. Stützle, T. E. Exner, "Empirical scoring functions for advanced protein-ligand docking with PLANTS," Journal of Chemical Information and Modeling, 49 (2009) 84-96.
31. J.H. McKie, K.T. Douglas, C. Chan, S.A. Roser, R. Yates, M. Read, J.E. Hyde, M.J. Dascombe, Y.Y., W. Sirawaraporn, "Rational drug design approach for overcoming drug resistance: Application to pyrimethamine resistance in malaria," J. Med. Chem., 41 (1998) 1367-1370.